See more : Rubis (RBSFY) Income Statement Analysis – Financial Results
Complete financial analysis of AiXin Life International, Inc. (AIXN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of AiXin Life International, Inc., a leading company in the Food Distribution industry within the Consumer Defensive sector.
- Nation International Edutainment Public Company Limited (NINE.BK) Income Statement Analysis – Financial Results
- Skjern Bank A/S (SKJE.CO) Income Statement Analysis – Financial Results
- Graphex Group Limited (6128.HK) Income Statement Analysis – Financial Results
- Cominix Co.,Ltd. (3173.T) Income Statement Analysis – Financial Results
- Huazhang Technology Holding Limited (1673.HK) Income Statement Analysis – Financial Results
AiXin Life International, Inc. (AIXN)
About AiXin Life International, Inc.
AiXin Life International, Inc., together with its subsidiaries markets and sells nutritional consumer products and supplements in China. It operates through three segments: Advertising and Products, Pharmacies, and Hotels. The company sells products through its pharmacies, sales offices, exhibition events, and person-to-person marketing, as well as online. In addition, it operates the Shangyan Hotel located in the Jinniu District, Chengdu City. AiXin Life International, Inc. was incorporated in 1987 and is based in Chengdu, China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.09M | 2.71M | 3.07M | 2.45M | 3.42M | 414.28K | 688.10K | 3.08M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 3.43M | 1.10M | 535.49K | 224.68K | 388.92K | 159.17K | 258.04K | 1.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 664.78K | 1.61M | 2.53M | 2.23M | 3.03M | 255.12K | 430.06K | 1.73M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 16.25% | 59.27% | 82.54% | 90.83% | 88.62% | 61.58% | 62.50% | 56.12% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 2.32M | 1.77M | 1.41M | 1.17M | 1.20M | 1.04M | 4.82M | 2.64M | 27.05K | 20.05K | 18.50K | 24.21K | 19.38K | 19.14K | 19.88K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 888.75K | 787.64K | 470.80K | 244.20K | 1.02M | 499.53K | 698.33K | 1.15M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 3.16M | 2.55M | 1.88M | 1.42M | 2.22M | 1.54M | 5.52M | 3.79M | 27.05K | 20.05K | 18.50K | 24.21K | 19.38K | 19.14K | 19.88K | 23.61K | 21.25K | 7.73K | 19.30K | 0.00 | 0.00 |
Other Expenses | 0.00 | 1.62M | 681.52K | 13.62K | 48.88K | -7.97K | -545.00 | -9.63K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.48K |
Operating Expenses | 3.16M | 4.17M | 2.56M | 1.43M | 2.27M | 1.60M | 5.53M | 3.80M | 27.05K | 20.05K | 18.50K | 24.21K | 19.38K | 19.14K | 19.88K | 23.61K | 21.25K | 7.73K | 19.30K | 0.00 | 6.48K |
Cost & Expenses | 6.59M | 5.28M | 3.09M | 1.66M | 2.66M | 1.75M | 5.79M | 5.15M | 27.05K | 20.05K | 18.50K | 24.21K | 19.38K | 19.14K | 19.88K | 23.61K | 21.25K | 7.73K | 19.30K | 0.00 | 6.48K |
Interest Income | 838.00 | 4.88K | 4.11K | 537.58K | 262.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 7.62M | 0.00 | 0.00 | 0.00 | 1.06K | 761.00 | 669.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 621.00 | 831.00 | 18.00 | -21.25K | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 410.69K | 185.57K | 96.11K | 43.46K | 78.52K | 165.78K | 196.66K | 211.11K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -19.76K | -20.71K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | -2.09M | -2.39M | 69.17K | 837.92K | 838.46K | -1.18M | -4.06M | -1.86M | -27.05K | -20.05K | -18.50K | -24.21K | -19.38K | -19.14K | -19.88K | -23.61K | -21.25K | -7.73K | -19.30K | 0.00 | -6.48K |
EBITDA Ratio | -51.06% | 53.16% | 2.26% | 34.19% | 25.48% | -285.53% | -713.08% | -60.61% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -2.50M | 1.25M | -26.94K | 794.46K | 759.93K | -1.34M | -5.12M | -2.07M | -27.05K | -20.05K | -18.50K | -24.21K | -19.38K | 621.00 | 831.00 | -23.61K | -21.25K | -7.73K | -19.30K | 0.00 | -6.48K |
Operating Income Ratio | -61.10% | 46.31% | -0.88% | 32.41% | 22.23% | -323.62% | -743.69% | -67.15% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 427.63K | -3.80M | 34.02K | 563.18K | 1.13M | -9.03K | 862.06K | -10.30K | 24.73K | 7.00K | 1.55K | 0.00 | 4.83K | -383.00 | 0.00 | 0.00 | 0.00 | -13.52K | 0.00 | 0.00 | 0.00 |
Income Before Tax | -2.07M | -6.37M | 7.09K | 1.36M | 1.89M | -1.35M | -4.26M | -2.08M | -27.05K | -20.05K | -18.50K | -24.21K | -19.38K | -19.76K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | -50.64% | -235.11% | 0.23% | 55.39% | 55.42% | -325.80% | -618.41% | -67.48% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 19.52K | 1.10K | 274.32K | 340.13K | 32.32K | 9.03K | -848.90K | 10.30K | 0.00 | 0.00 | 0.00 | 24.21K | 19.38K | 19.76K | 20.71K | 23.63K | 21.25K | 7.73K | 19.30K | 0.00 | 0.00 |
Net Income | -2.09M | -6.37M | -267.24K | 1.02M | 1.89M | -1.35M | -4.26M | -2.08M | -27.05K | -20.05K | -18.50K | -24.21K | -19.38K | -19.76K | -20.71K | -23.63K | -21.25K | -7.73K | -19.30K | 0.00 | 0.00 |
Net Income Ratio | -51.12% | -235.15% | -8.72% | 41.51% | 55.42% | -325.80% | -618.41% | -67.48% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -0.08 | -0.25 | -0.01 | 0.03 | 0.05 | -0.04 | -0.12 | -0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.10 | -0.14 | -0.39 | -0.20 | -0.51 | 0.00 | 0.00 |
EPS Diluted | -0.08 | -0.25 | -0.01 | 0.03 | 0.05 | -0.04 | -0.12 | -0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.10 | -0.14 | -0.39 | -0.20 | -0.51 | 0.00 | 0.00 |
Weighted Avg Shares Out | 25.00M | 25.00M | 25.00M | 32.80M | 37.22M | 36.12M | 34.41M | 32.50M | 5.68M | 5.68M | 5.68M | 5.68M | 5.68M | 3.25M | 198.67K | 170.57K | 54.20K | 37.96K | 37.70K | 0.00 | 0.00 |
Weighted Avg Shares Out (Dil) | 25.00M | 25.00M | 25.00M | 32.80M | 37.22M | 36.12M | 34.41M | 34.10M | 5.68M | 5.68M | 5.68M | 5.68M | 5.68M | 3.25M | 198.67K | 170.57K | 54.20K | 37.96K | 37.70K | 0.00 | 0.00 |
AiXin Life International Seeks $7 Million U.S. IPO
AiXin Life International, Inc. (OTCQX: AIXN) Announces Acquisitions of Hotel and Pharmacy Chain
OTC Markets Group Welcomes AiXin Life International, Inc. to OTCQX
Source: https://incomestatements.info
Category: Stock Reports